Kalkan, R. Et Al. 2015. IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme. GENE , vol.554, no.1 , 81-86.

Kalkan, R., Atli, E. I., Ozdemir, M., Ciftci, E., Aydin, H. E., ARTAN, S., ... ARSLANTAŞ, A.(2015). IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme. GENE , vol.554, no.1, 81-86.

Kalkan, Rasime Et Al. "IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme," GENE , vol.554, no.1, 81-86, 2015

Kalkan, Rasime Et Al. "IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme." GENE , vol.554, no.1, pp.81-86, 2015

Kalkan, R. Et Al. (2015) . "IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme." GENE , vol.554, no.1, pp.81-86.

@article{article, author={Rasime Kalkan Et Al. }, title={IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme}, journal={GENE}, year=2015, pages={81-86} }